Karyopharm Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $385.0M | $305.3M | $190.5M |
| FY2022 | $374.8M | $358.2M | $135.2M |
| FY2023 | $376.6M | $240.4M | $52.2M |
| FY2024 | $350.4M | $164.4M | $62.5M |
| FY2025 | $401.3M | $108.4M | $60.5M |